Global Oncology Radiopharmaceuticals Market Research Report 2022-2030

Report Summary

The Oncology Radiopharmaceuticals Market research report provides an in-depth analysis of the currents trends, latest expansions, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2015 and 2021 and also provides the forecast data from year 2022 to 2030 which is based on revenue (USD Million). With the help of all these information research report helps the market contributors to improve market positions. With the help of all these insights Oncology Radiopharmaceuticals Market research report recommends a business strategy for present market participants to strengthen their position in the market.
According to the report, the Oncology Radiopharmaceuticals Market size was USD xx million and it is expected to reach USD xx million by the end of 2030, with a CAGR of xx% during 2022-2030.

Radiation and radioactive compounds play a crucial role in therapeutic and diagnostic approaches in oncology. From last few decades radiotherapy is used in cancer diagnostic and therapeutic applications.  Radiation therapy is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Oncology Radiopharmaceuticals Market along with their effects over the forecast period.

Global Oncology Radiopharmaceuticals Market Segmentation:
By Type:
•	Radium-223 dichloride
•	Sodium iodide I-131
•	Lobenguane iodine-131
•	Lutetium-177
•	Yttrium-90
•	Fludeoxyglucose F 18
•	Gallium Citrate Ga 67
•	Technetium-99m
•	Others

By Application:
•	Diagnosis
•	Treatment

Major Key Players for Global Oncology Radiopharmaceuticals Market:
Siemens Healthcare GmbH, Novartis AG, Curium, GE Healthcare, Lantheus Medical Imaging, Inc., International Isotopes, Inc., Nordion, Eckert & Zieger, Acrotech Biopharma, Blue Earth Diagnostics, Zionexa, Bayer AG, Jubilant Pharma Limited, and Cardinal Health

Global Oncology Radiopharmaceuticals Market Segmentation by Regions:
In regional analysis, Oncology Radiopharmaceuticals Market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Oncology Radiopharmaceuticals Market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Important Points Covered by Report:
To analyze the value of the Oncology Radiopharmaceuticals Market, according to the key region.
To study the Oncology Radiopharmaceuticals Market current trends, prospects and also their participation in the entire sector.
Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
Report provides the detailed information about drivers, restraints and future scope of Oncology Radiopharmaceuticals Market.
Report covers the information about historic data analysis as well as forecast period analysis.

Table of content

Table of Contents
Table of Contents

1.    Preface
        1.1.    Report Scope and Description
        1.2.    Research Methodology
                1.2.1.    Phase I-Secondary Research
                1.2.2.    Phase II-Primary Research
                1.2.3.    Phase II-Expert Panel Review
                1.2.4.    Assumptions
                1.2.5.    Approach Adopted

2.    Executive Summary
        2.1.    Global Oncology Radiopharmaceuticals Market Snapshot
                2.1.1.    Global Oncology Radiopharmaceuticals Market, By Type, 2021
                2.1.2.    Global Oncology Radiopharmaceuticals Market, By Application, 2021
                2.1.3.    Global Oncology Radiopharmaceuticals Market, By Geography, 2021

3.    Global Oncology Radiopharmaceuticals Market Dynamics
        3.1.    Market Overview
        3.2.    Market Inclination Insights Analysis
        3.3.    Drivers
        3.4.    Challenges
        3.5.    Future Prospects
        3.6.    Impact Analysis of Drivers and Challenges During the Forecast Period, (2016-2026)
4. 	Oncology Radiopharmaceuticals Market Overview
4.1	Product Overview and Scope of Pharmacy Automation Robot
4.2   Oncology Radiopharmaceuticals Market Segmentation by Type
4.2.1 Global Production Market Share of Oncology Radiopharmaceuticals by Type in 2022
	4.2.1 Type 1
	4.2.2 Type 2
	4.2.3 Type 3
4.3 Oncology Radiopharmaceuticals Market Segmentation by Application
4.3.1 Oncology Radiopharmaceuticals Consumption Market Share by Application in 2022
	4.3.2 Application 1
	4.3.3 Application 2
	4.3.4 Application 3
4.4 Oncology Radiopharmaceuticals Market Segmentation by Regions
	4.4.1 North America
	4.4.2 Europe
	4.4.3 Asia Pacific
	4.4.4 Latin America
	4.4.5 Middle East & Africa
4.5 Global Market Size (Value) of Oncology Radiopharmaceuticals (2022-2030)
5.   North America Oncology Radiopharmaceuticals Market Analysis, 2022 – 2030
        5.1.    North America Oncology Radiopharmaceuticals Market Size (US$), By Type, 2022 – 2030
        5.2.    North America Oncology Radiopharmaceuticals Market Size (US$), By Application, 2022 – 2030
        5.3.    North America Oncology Radiopharmaceuticals Market Size (US$), By End-use, 2022 – 2030
        5.4.    North America Oncology Radiopharmaceuticals Market Size (US$), By Country, 2022 – 2030
                5.4.1.    U.S.
                5.4.2.    Canada
6.    Europe Oncology Radiopharmaceuticals Market Analysis, 2022 – 2030
        6.1.    Europe Oncology Radiopharmaceuticals Market Size (US$), By Type, 2022 – 2030
        6.2.    Europe Oncology Radiopharmaceuticals Market Size (US$), By Application, 2022 – 2030
        6.3.    Europe Oncology Radiopharmaceuticals Market Size (US$), By End-use, 2022 – 2030
        6.4.    Europe Oncology Radiopharmaceuticals Market Size (US$), By Country, 2022 – 2030
                6.4.1.    U.K.
                6.4.2.    Germany
                6.4.3.    France
                6.4.4.    Rest of Europe
7.    Asia Pacific Oncology Radiopharmaceuticals Market Analysis, 2022 – 2030
        7.1.    Asia Pacific Oncology Radiopharmaceuticals Market Size (US$), By Type, 2022 – 2030
        7.2.    Asia Pacific Oncology Radiopharmaceuticals Market Size (US$), By Application, 2022 – 2030
        7.3.    Asia Pacific Oncology Radiopharmaceuticals Market Size (US$), By End-use, 2022 – 2030
        7.4.    Asia Pacific Oncology Radiopharmaceuticals Market Size (US$), By Country, 2022 – 2030
                7.4.1.    China
                7.4.2.    Japan
                7.4.3.    India
                7.4.4.    Rest of Asia Pacific
8.    Latin America Oncology Radiopharmaceuticals Market Analysis, 2022 – 2030
        8.1.    Latin America Oncology Radiopharmaceuticals Market Size (US$), By Type, 2022 – 2030
        8.2.    Latin America Oncology Radiopharmaceuticals Market Size (US$), By Application, 2022 – 2030
        8.3.    Latin America Oncology Radiopharmaceuticals Market Size (US$), By End-use, 2022 – 2030
        8.4.    Latin America Oncology Radiopharmaceuticals Market Size (US$), By Country, 2022 – 2030
                8.4.1.    Brazil
                8.4.2.    Mexico
                8.4.3.    Rest of Latin America
9.    Middle East & Africa (MEA) Oncology Radiopharmaceuticals Market Analysis, 2022 – 2030
          9.1.     MEA Oncology Radiopharmaceuticals Market Size (US$), By Type, 2022 – 2030
          9.2.    MEA Oncology Radiopharmaceuticals Market Size (US$), By Application, 2022 – 2030
          9.3.    MEA Oncology Radiopharmaceuticals Market Size (US$), By End-use, 2022 – 2030
          9.4.    MEA Oncology Radiopharmaceuticals Market Size (US$), By Region, 2022 – 2030
                  9.4.1.    GCC Countries
                  9.4.2.    South Africa
                  9.4.3.    Rest of MEA
10.    Company Profiles
          12.1.    Competitive Analysis
          12.2.    Market Positioning of Key Vendors
          12.3.    Key Strategies adopted by the Leading Players
List of Tables
TABLE 1 Market Snapshot: Global Oncology Radiopharmaceuticals Market 
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 North America Oncology Radiopharmaceuticals Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 5 North America Oncology Radiopharmaceuticals Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 6 North America Oncology Radiopharmaceuticals Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
TABLE 7 Europe Oncology Radiopharmaceuticals Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 8 Europe Oncology Radiopharmaceuticals Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 9 Europe Oncology Radiopharmaceuticals Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
TABLE 10 Asia Pacific Oncology Radiopharmaceuticals Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 11 Asia Pacific Oncology Radiopharmaceuticals Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 12 Asia Pacific Oncology Radiopharmaceuticals Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
TABLE 13 Latin America Oncology Radiopharmaceuticals Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 14 Latin America Oncology Radiopharmaceuticals Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 15 Latin America Oncology Radiopharmaceuticals Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
TABLE 16 MEA Oncology Radiopharmaceuticals Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 17 MEA Oncology Radiopharmaceuticals Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 18 MEA Oncology Radiopharmaceuticals Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
        
List of Figures
FIG. 1 Global Oncology Radiopharmaceuticals Market: Market Segmentation
FIG. 2 Global Oncology Radiopharmaceuticals Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Oncology Radiopharmaceuticals Market, By Type, 2021 (US$ Mn)
FIG. 5 Global Oncology Radiopharmaceuticals Market, By Application, 2021 (US$ Mn)
FIG. 6 Global Oncology Radiopharmaceuticals Market, By End-use, 2021 (US$ Mn)
FIG. 7 Global Oncology Radiopharmaceuticals Market, By Geography, 2021 (US$ Mn)
FIG. 8 Global Oncology Radiopharmaceuticals Market Revenue and Growth, 2022 – 2030, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition
FIG. 10 Market Positioning of Key Oncology Radiopharmaceuticals Market Providers, 2021
FIG. 11 Global Oncology Radiopharmaceuticals Market Revenue Contribution, By Type, 2022 & 2030(Value %)
FIG. 12 Global Oncology Radiopharmaceuticals Market Revenue Contribution, By Application, 2022 & 2030(Value %)
FIG. 13 Global Oncology Radiopharmaceuticals Market Revenue Contribution, By End-use, 2022 & 2030(Value %)
FIG. 14 North America Oncology Radiopharmaceuticals Market Revenue, 2022 – 2030, (US$ Mn)
FIG. 15 Europe Oncology Radiopharmaceuticals Market Revenue, 2022 – 2030, (US$ Mn)
FIG. 16 Asia Pacific Oncology Radiopharmaceuticals Market Revenue, 2022 – 2030, (US$ Mn)
FIG. 17 Latin America Oncology Radiopharmaceuticals Market Revenue, 2022 – 2030, (US$ Mn)
FIG. 18 MEA Oncology Radiopharmaceuticals Market Revenue, 2022 – 2030, (US$ Mn)